MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]
Medicamen Biotech Limited
MEDICAMEQ
Market Cap₹327Cr.
Current Price₹242
High / Low₹454/212
Stock P/E34.8
Book Value₹206
Dividend Yield0.41%
ROCE5.10%
ROE3.78%
Face Value₹10.0
Incorporated in 1993, Medicamen Biotech Ltd is a research-led pharmaceutical company involved in developing, manufacturing, and marketing generic finished dosage formulations, and Oncology Formulations[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 16:58:04